drugset / Trial / NCT02900131

Efficacy, Safety and Dose Finding Trial of Topical Jaungo Application in Atopic Dermatitis Patients

NCT02900131 ↗

Phase 2 Completed 34 enrolled Kyung Hee University Hospital at Gangdong
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Atopic Dermatitis is a chronic relapsing eczematous skin disease with increasing prevalence. Complementary and alternative medical approaches have been employed to relieve symptoms of Atopic Dermatitis. We aim to establish basic clinical efficacy and safety data for Jaungo in patients with Atopic Dermatitis.

Timeline

Start
2016-09-19
Primary completion
2017-03-16
Completion
2017-03-16

Drugs

EvaluationDrugModalityDoseRoute
Subject Jaungo Traditional medicine (herbal / TCM) — Topical

Indications